The demonstration in human serum of "conglutinogen-activating factor" and its effect on the third component of complement
about
Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infectionStructural basis for complement factor I control and its disease-associated sequence polymorphismsInteraction of beta1H globulin with cell-bound C3b: quantitative analysis of binding and influence of alternative pathway components on bindingHuman complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solutionEffects of lead and mercury on the blood proteome of childrenRat complement factor I: molecular cloning, sequencing and expression in tissues and isolated cells.Use of fecal volatile organic compound analysis to discriminate between non-vaccinated and BCG-Vaccinated cattle prior to and after Mycobacterium bovis challenge.Serum-free culture of hamster lymphoid cells and differential inhibition of lipopolysaccharide stimulation by isologous serum.Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man.Human lymphocytes bear membrane receptors for C3b and C3dThird component of complement (C3): structural properties in relation to functionsC3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.A molecular concept of the properdin pathway.Soluble host defense lectins in innate immunity to influenza virusThe enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors.Complement-dependent release of immune complexes from the lymphocyte membrane.Receptor for the fourth component of complement on human B lymphocytes and cultured human lymphoblastoid cellsRelease of soluble immune complexes from immune adherence receptors on human erythrocytes is mediated by C3b inactivator independently of Beta 1H and is accompanied by generation of C3c.Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3bThe role of membrane receptors for C3b and C3d in phagocytosisActivation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteinsIdentification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes.Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies.Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.The membrane attack mechanism of complement. Isolation and subunit composition of the C5b-9 complex.Ultrastructure and composition of bovine conglutinin.The cDNA cloning of conglutinin and identification of liver as a primary site of synthesis of conglutinin in members of the BovidaeCirculating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.Inactivator of the third component of complement as an inhibitor in the properdin pathway.Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.Bovine serum conglutinin is a lectin which binds non-reducing terminal N-acetylglucosamine, mannose and fucose residues.Isolation and analysis of the mechanism of action of an inactivator of C4b in normal human serumThe influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation.The opsonic fragment of the third component of human complement (C3).Collectins--soluble proteins containing collagenous regions and lectin domains--and their roles in innate immunity.Preparation of test cells for the antiglobulin test.C3d antiglobulin haemagglutination of human red blood cells. A demonstration of two types of cell-bound C3d by means of typsin digestion.Specificity of human lymphocyte complement receptors.Studies on the mechanism of phagocytosis. I. Requirements for circumferential attachment of particle-bound ligands to specific receptors on the macrophage plasma membrane.Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes.
P2860
Q24300424-2EF0EF95-DED6-4BFE-8D44-3B059F1B5FBBQ24622871-53385FAC-E1A8-455F-8DBD-E2464ED1F1C7Q24684253-0F56D3F8-A736-4596-BAC3-2E5D4F6EF8F4Q24684822-3B66D079-8178-43D9-8BFB-4E478ECB2D0BQ28383202-31353298-EECD-4546-8C90-FE3B3F8BA700Q30821832-5E2F4905-CC8B-4DC1-8114-F99420601BD0Q33883795-BCEC80CD-CDC8-4E3B-923B-9F3A6C241B14Q34402276-DCF36308-93A5-4789-A2B2-5FB32C155706Q34464887-7F9E2628-B524-4BE2-A882-A07B5609F3ECQ34516326-23A8CE7B-9037-42F2-904F-3C3608EBAAE8Q35080082-258AE0BA-D64E-4CCA-8299-700F4FDF3927Q35201919-E12BE1B3-EBE9-4575-AAEA-0A2D4F257A85Q35986109-CF7DA95C-4670-4D88-8A4F-8EEFC7044132Q35994652-B9BD2013-7216-44A2-A9E8-C6A857CD95E6Q36269730-85DD06CD-E967-4235-8555-CC84F7E1CB88Q36272531-1173F807-2558-4FEB-A546-348B0AB6C811Q36273679-1963EBCE-814F-4E9B-80C1-2294CF0CC9EEQ36308579-E2042218-F95F-45B2-A6D3-9D01DD659439Q36334997-05668EAA-0785-412E-9570-76F8193DA19AQ36335168-D03ACA91-8A7F-45E5-B8A6-FFDC870894AFQ36335627-FD5851F2-8584-45CA-9760-20E9407F72A7Q36346014-61E20672-2B47-4808-B89D-6A75CA5775BBQ36346672-AF5C35E3-70D8-416F-92A7-CB1A2E4989A1Q36348883-2CBB53FF-D255-4985-96B6-DDE0A7AB16D9Q36357822-57A8E0D1-5D82-4D37-AB61-13E36EE6F0CEQ36476145-2738039E-897C-498C-A97E-BFB693446057Q36695983-B86785D0-B5AE-4747-94A5-4A95B4A3F992Q37044336-7B4DD4F4-65E4-4184-AD80-84DC98AD670FQ37496999-7FBF8990-6B18-4A86-A676-E906196F7578Q38309807-FB25C9B4-1F89-41DA-A899-5BA0AE6E2519Q38345223-84677ADB-95A7-4CB4-9001-76B34FA356F7Q39323582-5EC3E626-41FC-4052-99FB-F59314FB8107Q39349484-86749B46-2434-42F3-A98C-A654FD9C15F9Q40317490-20D71186-8C6C-463B-98DF-BEDEA13892FEQ40647972-26747DC2-948B-49C2-8742-7397022A5BFCQ41265336-FF47E53F-2953-4F4B-8319-AE793EC8A242Q41806874-8C27EF47-0F42-4B2B-912A-53B1EB100A89Q41832075-25F7597E-4311-4BC9-9CDE-884AB4B68279Q41867175-C693973B-4448-4D07-881D-EAE7059BFCFBQ41894352-F0591F15-9B73-428A-99D3-84048D2A75EB
P2860
The demonstration in human serum of "conglutinogen-activating factor" and its effect on the third component of complement
description
1968 nî lūn-bûn
@nan
1968 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1968 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1968年の論文
@ja
1968年論文
@yue
1968年論文
@zh-hant
1968年論文
@zh-hk
1968年論文
@zh-mo
1968年論文
@zh-tw
1968年论文
@wuu
name
The demonstration in human ser ...... third component of complement
@ast
The demonstration in human ser ...... third component of complement
@en
The demonstration in human ser ...... third component of complement
@nl
type
label
The demonstration in human ser ...... third component of complement
@ast
The demonstration in human ser ...... third component of complement
@en
The demonstration in human ser ...... third component of complement
@nl
prefLabel
The demonstration in human ser ...... third component of complement
@ast
The demonstration in human ser ...... third component of complement
@en
The demonstration in human ser ...... third component of complement
@nl
P1476
The demonstration in human ser ...... third component of complement
@en
P2093
H J Müller-Eberhard
P J Lachmann
P407
P577
1968-04-01T00:00:00Z